Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 4, 2005, Pages 363-369

  Albarellos, G A ^a   Ambros, L A ^a   Landoni, M F ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ASSAY; BLOOD SAMPLING; CAT; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; KLEBSIELLA PNEUMONIAE; MALE; MATHEMATICAL ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CATS; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS, INTRAVENOUS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN;

BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

EID: 23244451233     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2005.00669.x     Document Type: Article

References (44)

1. Albarellos, G.A., Bonafine, R.R., Kreil, V.E., Ambros, L.A., Montoya, L. & Hallu, R.E. (2003) A non-surgical jugular catheterization technique for multiple blood sampling in cats. Laboratory Animals, 37, 188-192.
2. Auten, G.M., Preheim, L.C., Sookpranee, M., Bittner, M.J., Sookpranee, T. & Vibhagool, A. (1991) High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections. Antimicrobial Agents and Chemotherapy, 35, 2558-2561.
3. Baggot, J.D. (2001) The Physiological Basis of Veterinary Clinical Pharmacology. Blackwell Science Ltd., London, UK.
4. Bellmann, R., Kuchling, G., Dehghanyar, P., Zeitlinger, M., Minar, E., Mayer, B.X., Müller, M. & Joukhadar, C. (2004) Tissue pharmacokinetics of levofloxacin in human soft tissue infections. British Journal of Clinical Pharmacology, 57, 563-568.
5. Bennet, J.V., Brodie, J.L., Bennet, E.J. & Kirby, W.M. (1966) Simplified accurate method for antibiotic assay of clinical specimens. Applied Microbiology, 14, 170-177.
6. Brown, S.A. (1996) Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1-14.
7. Cheng, F.C, Tsai, T.R., Chen, Y.F., Hung, L.C. & Tsai, T.H. (2002) Pharmacokinetic study of levofloxacin in rat blood and bile by micro dialysis and high-performance liquid chromatography. Journal of Chromatography A, 961, 131-136.
8. Chien, S., Rogge, M.C., Gisclon, L.G., Curtin, C., Wong, F., Natarajan, J., Williams, R.R., Fowler, C.L., Cheung, W.K. & Chow, A.T. (1997) Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrobial Agents and Chemotherapy, 41, 2256-2260.
9. Chien, S., Wong, F.A., Fowler, C.L., Callery-D'Amico, S.V., Williams, R.R., Nayak, R. & Chow, A.T. (1998) Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers. Antimicrobial Agents and Chemotherapy, 42, 885-888.
10. Child, J., Mortiboy, D., Andrews, J.M., Chow, A.T. & Wise, R. (1995) Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid. Antimicrobial Agents and Chemotherapy, 39, 2749-2751.
11. Chow, A.T., Fowler, C., Williams, R.R., Morgan, N., Kaminski, S. & Natarajan, J. (2001) Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers. Antimicrobial Agents and Chemotherapy, 45, 2122-2125.
12. Chow, A.T., Chen, A., Lattime, H., Morgan, N., Wong, F., Fowler, C. & Williams, R.R. (2002) Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses. Journal of Clinical Pharmacy and Therapeutics, 27, 143-150.
13. Craig, W.A. (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26, 1-12.
14. Destache, C.J., Pakiz, C.B., Larsen, C., Owens, H. & Dash, A.K. (2001) Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model. Journal of Antimicrobial Chemotherapy, 47, 611-615.
15. Drusano, G.L., Johnson, D.E., Rosen, M. & Standiford, H.C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483-490.
16. Dudley, M.N. (1991) Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. The American Journal of Medicine, 91 (Suppl. 6A), 45-50.
17. Fish, D.N. & Chow, A.T. (1997) The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinetics, 32, 101-119.
18. Forrest, A., Nix, D.E., Ballow, C.H, Goss, T.F., Birmingham, M.C. & Schentag, J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37, 1073-1081.
19. Fu, K.P., Lafredo, S.C., Foleno, B., Isaacson, D.M., Barrett, J.F., Tobia, A.J. & Rosenthale, M.E. (1992) In Vitro and In Vivo antibacterial activities of levofloxacin (l-Ofloxacin), an optically active ofloxacin. Antimicrobial Agents and Chemotherapy, 36, 860-866.
20. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker Inc., New York.
21. Graham, J.P., Lipman, A.H., Newell, S.M. & Roberts, G.D. (2000) Esophageal transit of capsules in clinically normal cats. American Journal of Veterinary Research, 61, 655-657.
22. Hyatt, J.M., McKinnon, P.S., Zimmer, G.S. & Schentag, J.J. (1995) The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clinical Pharmacokinetics, 28, 143-160.
23. Hurst, M., Lamb, H.M., Scott, L.J. & Figgitt, D.P. (2002) Levofloxacin. An updated review of its use in the treatment of bacterial infections. Drugs, 62, 2127-2167.
24. Langtry, H.D. & Lamb, H.M. (1998) Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 56, 487-515.
25. Lee, L., Hafkin, B., Lee, I., Hoh, J. & Dix, R (1997) Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Antimicrobial Agents and Chemotherapy, 41, 2196-2200.
26. Lode, H., Borner, K. & Koeppe, P. (1998) Pharmacodynamics of fluoroquinolones. Clinical Infectious Diseases, 27, 33-39.
27. Lubasch, A., Keller, L, Borner, K., Koeppe, P. & Lode, H. (2000) Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrobial Agents and Chemotherapy, 44, 2600-2603.
28. Madaras-Kelly, K.J., Ostergaard, B.E., Baeker Hovde, L. & Rotschafer, J.C. (1996) Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy, 40, 627-632.
29. Marshall, S.A. & Jones, R.N. (1993) In Vitro activity of DU-6859a, a new fluorocyclopropyl quinolone. Antimicrobial Agents and Chemotherapy, 37, 2747-2753.
30. Nakamori, Y., Miyashita, Y., Nakatani, I. & Nakata, K. (1995) Levofloxacin: Penetration into sputum and once-daily treatment of respiratory tract infections. Drugs, 49 (Suppl. 2), 418-419.
31. Okazaki, O., Kojima, C., Hakusui, H. & Nakashima, M. (1991) Enantioselective disposition of ofloxacin in humans. Antimicrobial Agents and Chemotherapy, 35, 2106-2109.
32. Pea, F., Di Qual, E., Cusenza, A., Brollo, L., Baldassarre, M. & Furlanut, M. (2003a) Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia. Clinical Pharmacokinetics, 42, 589-598.
33. Pea, F., Pavan, F., Nascimben, E., Benetton, C. Scotton, P.G., Vaglia, A. & Furlanut, M. (2003b) Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrobial Agents and Chemotherapy, 47, 3104-3108.
34. Schentag, J.J., Nix, D.E. & Forrest, A. (1993) Pharmacodynamics of the fluoroquinolones. In: Quinolone Antimicrobial Agents, Chapter 12, 2nd edn. Eds Hooper, D.C. & Wolfson, J.S. pp. 259-271. American Society for Microbiology, Washington, DC.
35. Schwartz, G. (1978) Estimating the dimension of a model. Annals of Statistics, 6, 461-464.
36. Shojaee Aliabadi, F. & Lees, P. (1997) Pharmacodynamic and pharmacokinetic inter-relationships of antibacterial drugs. Journal of Veterinary Pharmacology and Therapeutics, 20 (Suppl. 1), 14-17.
37. Stahlmann, R. & Lode, H. (1999) Toxicity of quinolones. Drugs, 58 (Suppl. 2), 37-42.
38. Takahashi, Y., Masuda, N., Otsuki, M., Miki, M. & Nishino, T. (1997) In Vitro activity of HSR-903, a new quinolone. Antimicrobial Agents and Chemotherapy, 41, 1326-1330.
39. Toutain, P.L., Del Castillo, J.R.E. & Bousquet-Mélou, A. (2002) The pharmacokinetic pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105-114.
40. Une, T., Fujimoto, T., Sato, K. & Osada, Y. (1988) In Vitro activity of DR-3355, an optically active ofloxacin. Antimicrobial Agents and Chemotherapy, 32, 1336-1340.
41. Walker, R.D. (2000) The use of fluoroquinolones for companion animal antimicrobial therapy. Australian Veterinary Journal, 78, 84-90.
42. Westfall, D.S., Twedt, D.C., Steyn, P.F., Oberhauser, E.B. & VanCleave, J.W. (2001) Evaluation of esophageal transit of tablets and capsules in 30 cats. Journal of Veterinary Internal Medicine, 15, 467-470.
43. Wright, D.H., Brown, G.H., Peterson, M.L. & Rotschafer, J.C. (2000) Application of fluoroquinolone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669-683.
44. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6,165-175.